Skip to content

Doximity DOCS Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Veeva Systems logo
Veeva SystemsVEEV
Solventum logo
SolventumSOLV
CVS Health logo
CVS HealthCVS
IQVIA logo
IQVIAIQV
Charles River Laboratories logo
Charles River LaboratoriesCRL
Genpact logo
GenpactG

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Doximity’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's common stock, shares, outstanding?
Doximity (DOCS) reported common stock, shares, outstanding of $184.99M in Q4 2025.
How has Doximity's common stock, shares, outstanding changed year-over-year?
Doximity's common stock, shares, outstanding decreased by 1.4% year-over-year, from $187.58M to $184.99M.
What is the long-term trend for Doximity's common stock, shares, outstanding?
Over 4 years (2021 to 2025), Doximity's common stock, shares, outstanding has grown at a 22.9% compound annual growth rate (CAGR), from $82.91M to $188.88M.